These findings demonstrate the significant influence of GZMA+IFN-γ+CD8+TILs on the immune microenvironment in colon cancer, which in turn affects patient prognosis by modulating tumor cells expressing GSDMB. This evidence concerns the gene CD8A and neoplasm.